On the recordMay 16, 2016
Congress should not ask seniors to pay 20 percent of increasingly expensive therapies without due consideration of whether their money is being well spent.
Source
congress.govCongress should not ask seniors to pay 20 percent of increasingly expensive therapies without due consideration of whether their money is being well spent.
Pitts emphasizes the need for careful consideration of costs for seniors in Medicare.
Share
More from Joe Pitts
H.R. 1807, the Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015, sponsored by Rep. Danny Davis (IL) and Rep. Michael Burgess (TX) reauthorizes a sickle cell disease demonstration program.
Administrator Slavitt, CMS announced that APTC and CSR subsidies would be ended for 2016 enrollees who received APTCs in 2014 but did not reconcile these payments on their federal taxes.